097459128	097459128	CD	B-NP	O
|	|	NN	I-NP	O
SVMC	SVMC	NN	I-NP	O
|	|	NN	I-NP	O
09309168	09309168	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5331523	5331523	CD	B-NP	O
|	|	CC	I-NP	O
9/7/2003	9/7/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
SVT	SVT	NN	I-NP	I-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/22/2003	9/22/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/28/2003	10/28/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
COLLI	COLLI	NNP	B-NP	O
,	,	,	O	O
VIRGILIO	VIRGILIO	NNP	B-NP	O
S	S	NNP	I-NP	O
717-60-14-3	717-60-14-3	NNP	I-NP	O
Ma	Ma	NNP	I-NP	O
Ker	Ker	NNP	I-NP	O
Bast.cleve	Bast.cleve	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
4/19/03	4/19/03	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HAMEL	HAMEL	NNP	B-NP	O
,	,	,	O	O
ARNOLDO	ARNOLDO	NNP	B-NP	O
GRANVILLE	GRANVILLE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/2/03	1/2/03	CD	B-NP	O
by	by	IN	B-PP	O
RENOVA	RENOVA	NNP	B-NP	O
,	,	,	O	O
ANIBAL	ANIBAL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DEFINITE	DEFINITE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
G6PD	G6PD	NN	B-NP	O
DEFICIENCY	DEFICIENCY	NN	I-NP	O
DEFINITE	DEFINITE	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
G6PD	G6PD	NN	B-NP	O
DEFICIENCY	DEFICIENCY	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
LASIX	LASIX	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
October	October	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/2/03	1/2/03	CD	B-NP	O
by	by	IN	B-PP	O
OHARRA	OHARRA	NNP	B-NP	O
,	,	,	O	O
MILO	MILO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
METOPROLOL	METOPROLOL	NN	B-NP	B-protein
TARTRATE	TARTRATE	NN	I-NP	I-protein
12.5	12.5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-NP	O
60	60	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

TERAZOSIN	TERAZOSIN	NN	B-NP	O
HCL	HCL	NN	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
20	20	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

FLOVENT	FLOVENT	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
220	220	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
GH	GH	NN	B-NP	B-protein
PCP	PCP	NN	I-NP	I-protein
1-2	1-2	CD	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Quinine	Quinine	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
quinine	quinine	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
Sulfa	Sulfa	NN	B-NP	O
,	,	,	O	O
G6pd	G6pd	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
SVT	SVT	NN	B-NP	O
,	,	,	O	O
pulm	pulm	NN	B-NP	O
edema	edema	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SVT	SVT	NNP	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
glaucoma	glaucoma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
glaucoma	glaucoma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
copd	copd	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CT	CT	NNP	I-NP	O
scan	scan	NN	I-NP	O
chest	chest	NN	I-NP	O
:	:	:	O	O
resolving	resolve	VBG	B-VP	O
L	L	NN	B-NP	O
lingular/LUL	lingular/LUL	NN	I-NP	O
opacities/consolidative	opacities/consolidative	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

Slight	Slight	JJ	B-NP	O
residual	residual	JJ	I-NP	O
lingular	lingular	JJ	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
,	,	,	O	O
resolvins	resolvin	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NN	B-NP	O
:	:	:	O	O
normal	normal	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
root	root	NN	I-NP	O
;	;	:	O	O
LA	LA	NN	B-NP	O
normal	normal	JJ	I-NP	O
RA	RA	NN	I-NP	O
mod	mod	NN	I-NP	O
enlarged	enlarge	VBD	B-VP	O
;	;	:	O	O
RVH	RVH	NN	B-NP	O
,	,	,	O	O
enlarged	enlarged	JJ	B-NP	O
,	,	,	I-NP	O
mild	mild	JJ	I-NP	O
HK	HK	NN	I-NP	O
;	;	:	O	O
concentric	concentric	JJ	B-NP	O
,	,	,	I-NP	O
mild	mild	JJ	I-NP	O
LVH	LVH	NN	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
AR	AR	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
AS	AS	NN	I-NP	O
;	;	:	O	O
LV	LV	NN	B-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
;	;	:	O	O
mild	mild	JJ	B-NP	O
TR	TR	NN	I-NP	O
with	with	IN	B-PP	O
markedly	markedly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
PA	PA	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
63mmHg	63mmHg	NN	I-NP	O
+	+	SYM	B-NP	O
RA	RA	NN	I-NP	B-protein
pressure	pressure	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
71M	71M	NN	B-NP	O
COPD	COPD	NN	I-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
dysfuntion	dysfuntion	NN	I-NP	O
,	,	,	O	O
PAF	PAF	NN	B-NP	B-protein
,	,	,	O	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
narrow	narrow	JJ	B-NP	O
complex	complex	JJ	I-NP	O
SVT	SVT	NN	I-NP	O
,	,	,	O	O
decompensated	decompensate	VBD	B-VP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
presented	present	VBD	B-VP	O
after	after	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
DOE	DOE	NNP	B-NP	O
with	with	IN	B-PP	O
few	few	JJ	B-NP	O
steps	step	NNS	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
CP/palpitations	CP/palpitation	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	B-cell_line
140s	140	NNS	I-NP	I-cell_line
,	,	,	O	O
converted	convert	VBN	B-VP	O
to	to	TO	B-PP	O
SR	SR	NN	B-NP	B-protein
with	with	IN	B-PP	O
6	6	CD	B-NP	O
adenosine	adenosine	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

IMP	IMP	NN	B-NP	O
:	:	:	O	O
Likely	Likely	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
with	with	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
,	,	,	O	O
infectious	infectious	JJ	B-NP	O
vs.	vs.	NN	I-NP	O
ischemic	ischemic	JJ	B-ADJP	O
vs.	vs.	IN	B-PP	O
acute	acute	JJ	B-NP	B-protein
volume	volume	NN	I-NP	I-protein
overload	overload	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
dietary	dietary	JJ	I-NP	I-protein
noncompliance	noncompliance	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
vs.	vs.	IN	B-PP	O
medical	medical	JJ	B-NP	O
noncompliance	noncompliance	NN	I-NP	O
.	.	.	O	O

COURSE/PLAN	COURSE/PLAN	NN	B-NP	O
:	:	:	O	O
CV	CV	NN	B-NP	O
:	:	:	O	O
ROMI	ROMI	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
markedly	markedly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
R	R	NN	I-NP	O
heart	heart	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
,	,	,	O	O
LV	LV	NN	B-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
.	.	.	O	O

Diuresis	Diuresis	NN	B-NP	O
with	with	IN	B-PP	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
diuresed	diurese	VBD	B-VP	O
negative	negative	JJ	B-NP	O
1.5	1.5	CD	I-NP	O
liters	liter	NNS	I-NP	O
and	and	CC	O	O
symptomatically	symptomatically	RB	B-VP	O
was	be	VBD	I-VP	O
much	much	RB	I-VP	O
improved	improve	VBN	I-VP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

MIBI	MIBI	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
?	?	.	O	O

COPD	COPD	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

duonebs	duoneb	NNS	B-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
.	.	.	O	O

Stopping	Stop	VBG	B-VP	O
prednisone	prednisone	NN	B-NP	O
on	on	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

RENAL	RENAL	NNP	B-NP	O
:	:	:	O	O
follow	follow	JJ	B-NP	O
bun/cr	bun/cr	NN	I-NP	O
.	.	.	O	O

DISPO	DISPO	NN	B-NP	B-protein
:	:	:	O	O
Decompensated	Decompensate	VBN	B-NP	O
CHF	CHF	NN	I-NP	B-protein
likely	likely	RB	B-ADJP	O
in	in	IN	B-PP	O
setting	set	VBG	B-VP	O
of	of	IN	B-PP	O
dietary/medicine	dietary/medicine	NN	B-NP	O
non-compliance	non-compliance	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	O	O
counsel	counsel	NN	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
dietary	dietary	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
balance	balance	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Use	Use	NN	B-NP	O
home	home	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
medicines	medicine	NNS	B-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

Weigh	Weigh	VB	B-VP	O
yourself	yourself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
report	report	VB	B-VP	O
any	any	DT	B-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
or	or	CC	I-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

Limit	Limit	NN	B-NP	O
daily	daily	JJ	I-NP	O
salt	salt	NN	I-NP	O
intake	intake	NN	I-NP	O
as	as	IN	B-SBAR	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
cause	cause	VB	I-VP	O
fluid	fluid	NN	B-NP	O
to	to	TO	B-VP	O
build	build	VB	I-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
.	.	.	O	O

Use	Use	NN	B-NP	O
inhaler	inhaler	NN	I-NP	O
on	on	IN	B-PP	O
schedule	schedule	NN	B-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
breathing	breathing	NN	B-NP	O
.	.	.	O	O

Resume	Resume	NN	B-NP	O
normal	normal	JJ	I-NP	O
activity	activity	NN	I-NP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
tolerate	tolerate	VBP	B-VP	O
,	,	,	O	O
advancing	advance	VBG	B-VP	O
activity	activity	NN	B-NP	O
slowly	slowly	RB	B-ADVP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
MIBI	MIBI	NNP	B-NP	O
cardiac	cardiac	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Monitor	Monitor	NNP	B-NP	O
your	your	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
weight	weight	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
make	make	VB	B-VP	O
sure	sure	JJ	B-ADJP	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
gaining	gain	VBG	I-VP	O
weight	weight	NN	B-NP	O
from	from	IN	B-PP	O
day	day	NN	B-NP	O
to	to	TO	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
medicines	medicine	NNS	B-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

Schedule	Schedule	NNP	B-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
with	with	IN	B-PP	O
TWNMH	TWNMH	NN	B-NP	O
PCP	PCP	NN	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

Use	Use	NN	B-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
comfort	comfort	NN	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
KIVETT	KIVETT	NNP	B-NP	O
,	,	,	O	O
EDMUNDO	EDMUNDO	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ET480	ET480	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/19/03	4/19/03	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
25	25	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

